Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ST3GAL3 contributors: mct/ - updated : 19-11-2013
HGNC name ST3 beta-galactoside alpha-2,3-sialyltransferase 3
HGNC id 10866
Corresponding disease
EIEE15 Epileptic encephalopathy, early infantile 15
NSMR5 nonsyndromic mental retardation 5
Location 1p34.1      Physical location : 44.173.217 - 44.396.830
Synonym name
  • sialyltransferase 6 (N-acetyllacosaminide alpha 2,3-sialyltransferase)
  • Gal beta-1,3(4)GlcNAc alpha-2,3 sialyltransferase
  • CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
  • Synonym symbol(s) ST3GALII, ST3N, ST3GALIII, SIAT6, ST3GALI, EIEE15, MRT12, ST3GalIII
    EC.number 2.4.99.6
    DNA
    TYPE functioning gene
    STRUCTURE 223.63 kb     13 Exon(s)
    regulatory sequence Promoter
    Binding site   transcription factor
    text structure
  • pIII promoter in 5' upstream of exon 1
  • -303 to -1 region is important for transcriptional activity of the gene
  • several putative transcriptional factor binding sites such as Sp1, MZF1, MyoD, USF, AP1, Lyf1
  • Sp1 may be important for gene expression
  • potential negative and positive regulatory element within -544 to -303 and to -303 to -1 regions respectively
  • MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    13 - 2549 49 444 - 2010 19727557
  • also called A8 or variant 1/isoform a
  • the longest isoform
  • 12 - 2316 43 390 - 2010 19727557
  • also called A1 or variant 2/isoform b
  • lacks an alternate in frame exon, resulting in a shorter isoform A1 compared to isoform a
  • 7 - 1675 19 170 - 2010 19727557
  • also called A7 or variant 3/isoform c
  • a frameshift in the coding region, resulting in a shorter isoform A7 whith a distinct C-terminus compared to isoform a
  • 10 - 1977 31 277 - 2010 19727557
  • differences in coding regon but reading frame is maintained. A distinct and shorter C-terminus
  • also called B4 or variant 4/isoform d
  • 12 - 1630 - 155 - 2010 19727557
  • also called B7 or variant 5/isoform e
  • a frameshift resulting in a shorter isoform B7 with a distinct C-terminus
  • 13 splicing 2504 48 429 - 2010 19727557
  • also called B8 or variant 6/isoform f
  • an alternate in-frame splice site resulting in a shorter isoform B8
  • 11 - 2223 40 359 - 2010 19727557
  • also called C1 or variant 7/isoform g
  • reading frame is maintained but the resulting isoform C1 is shorter
  • 6 - 1582 15 139 - 2010 19727557
  • also called C7 or variant 8/isoform h
  • a frameshift resulting in a shorter isoform C7 with a distinct C-terminus
  • 12 - 2456 46 413 - 2010 19727557
  • also called C8 or variant 9/isoform i
  • lacks an alternate in frame segment, resulting in a shorter isoform C8
  • 12 - 2271 42 375 - 2010 19727557
  • also called variant 10/isoform j
  • reading frame is maintained but the resulting isoform B1 is shorter
  • 8 - 1836 - 185 - 2010 19727557
    8 - 1810 - 201 - 2010 19727557
    12 - 2204 - 345 - 2010 19727557
    11 - 2201 - 344 - 2010 19727557
    9 - 1952 - 261 - 2010 19727557
    8 - 1765 - 186 - 2010 19727557
    5 - 1510 - 101 - 2010 19727557
    8 - 1859 - 230 - 2010 19727557
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveliver   lowly
    Respiratorylung   lowly
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal  
    cell lineage
    cell lines leukemia, colon adenocarcinoma, prostate adenocarcinoma, and hepatocellular carcinoma cell lines
    fluid/secretion
    at STAGE
    physiological period fetal, pregnancy
    Text highly in fetal tissues, lowly in placenta
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • sialyl motifs L, S, and VS, (L and S previously demonstrated their involvement in the binding of donor and acceptor substrates)
  • region comprised between the sialyl motifs S and VS contains a stretch of four highly conserved residues, with the following consensus sequence (H/y)Y(Y/F/W/h)(E/D/q/g)
  • four N-glycan attachment sites in its catalytic domain that are potentially glycosylated (N-glycosylation appears to contribute to the proper folding and trafficking of the enzyme)
  • conjugated GlycoP
    isoforms Precursor the soluble form derives from the transmembrane form by proteolytic processing
    HOMOLOGY
    interspecies homolog to murine Siat6
    Homologene
    FAMILY
  • vertebrate sialyltransferase family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,Golgi
    text
  • type II membrane protein
  • membrane-bound form in tran-cisternae of Golgi
  • soluble form in body fluids
  • basic FUNCTION
  • transfering sialic acid to terminal positions on the carbohydrate groups of glycoproteins and glycolipids
  • being key determinants for a variety of cellular recognition processes
  • sialyltransferase involved in the biosynthesis of sialyl-Lewis epitopes on cell surface-expressed glycoproteins
  • CELLULAR PROCESS protein, post translation
    PHYSIOLOGICAL PROCESS
    text glycosylation
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • plays an important role in SIGLEC5 ligand formation and eosinophil apoptosis with resultant effects on eosinophilic inflammation in the lung
  • cell & other
    REGULATION
    Other regulated by all-trans-retinoic acid (RA) (RA is a significant regulator of GALM and other galactose-related genes in myeloid-monocytic cells, which could affect energy utilization and synthesis of cell-surface glycoproteins or glycolipids involved in cell motility, adhesion, and/or functional properties)
    ASSOCIATED DISORDERS
    corresponding disease(s) EIEE15 , NSMR5
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in the pancreatic adenocarcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS
  • ST3Gal-III heterozygote mice (deficient in expression of Siglec-F ligands) also had significantly enhanced OVA(OVA allergen)-induced eosinophilic airway inflammation associated with reduced eosinophil apoptosis